×
About 1,498 results

ALLMedicine™ Amphetamines Center

Research & Reviews  474 results

Pharmacokinetics of Synthetic Cathinones Found in Bath Salts in Mouse Brain and Plasma ...
https://doi.org/10.1007/s13318-021-00712-1 10.1038/npp.2012.204 10.2174/1570159X13666141210224137 10.1007/s13181-011-0193-z 10.1007/s12640-019-00020-2 10.1007/s00213-013-2967-2 10.1002/dta.1369 10.1124/dmd.112.050880 10.1002/jms.1859 10.1016/j.ntt.2017.08.001 10.1111/bcpt.12253 10.1111/j.1471-4159.2011.07632.x 10.1093/jat/bkw074 10.1038/npp.2016.213 10.3389/fpsyt.2017.00306 10.1016/j.drugalcdep.2017.07.011 10.1007/s00213-018-4962-0
European Journal of Drug Metabolism and Pharmacokinetics; Gearlds C, Bouldin JB et. al.

Aug 25th, 2021 - Approximately 10 years ago, "bath salts" became popular as legal alternatives to the psychostimulants cocaine and the amphetamines. These products contained synthetic cathinones, including 3,4-methylenedioxypyrovalerone (MDPV), 4-methylmethcathino...

A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Defi...
https://doi.org/10.1007/s40263-021-00848-3 10.1056/NEJMra1917069 10.1177/108705470000300403 10.1007/s00787-012-0286-5 10.1089/cap.2012.0085 10.1089/cap.2009.0033 10.1016/j.eurpsy.2017.05.021 10.1016/j.jaac.2019.12.009 10.1080/15374416.2015.1055859 10.1080/15374416.2015.1105138 10.1371/journal.pone.0180355 10.1016/j.jaac.2018.07.891 10.1016/S2215-0366(18)30269-4 10.1186/s13034-015-0083-2 10.1007/s00787-013-0393-y 10.1016/j.jaac.2020.03.009 10.1192/bjp.bp.111.096594 10.1097/CHI.0b013e31819c55b2 10.2147/JEP.S256586 10.1177/1087054719836159 10.1016/j.clinthera.2020.05.021 10.1016/j.clinthera.2021.01.027 10.1016/j.psychres.2020.113664 10.1097/00004583-199610000-00018 10.1016/j.biopsych.2005.01.027 10.1016/j.euroneuro.2015.12.023 10.4088/JCP.v67n0120 10.1177/1087054712441969 10.1080/14737175.2019.1628640 10.1186/1753-2000-1-10 10.1016/j.jaac.2011.10.012 10.1097/01.CHI.0000046908.27264.00 10.1016/j.jaac.2016.05.015 10.1016/j.jaac.2016.05.016 10.1089/cap.2015.0264 10.1542/peds.2010-1260 10.1176/appi.ajp.2009.09020233 10.1097/chi.0b013e3180323354 10.1089/cap.2013.0103 10.1001/jamapediatrics.2019.0905 10.1097/00007691-198412000-00001 10.1371/journal.pone.0063023 10.1007/s40263-014-0224-9 10.1097/01.chi.0000246056.83791.b6 10.1002/cpt.1409 10.1089/cap.2017.0157 10.1007/s10578-011-0220-y 10.3389/fpsyt.2019.00437 10.1177/1087054713518239 10.1016/S0002-7138(09)60506-9 10.1111/pcn.12913 10.23736/S0391-1772.19.02020-X 10.1080/1028415X.2016.1262097 10.1016/j.ajp.2019.101868 10.1089/cap.2010.0073 10.1016/j.imr.2021.100714 10.1177/000992280003900102
CNS Drugs; Cortese S, Newcorn JH et. al.

Aug 18th, 2021 - Stimulants (methylphenidate or amphetamines) are the recommended first-line option for the pharmacological treatment of individuals with attention deficit hyperactivity disorder (ADHD). However, some patients with ADHD will not respond optimally t...

Secular trends and regional variations in pharmacotherapy of attention-deficit/hyperact...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364007
BMC Psychiatry; Akmatov MK, Holstiege J et. al.

Aug 16th, 2021 - The study aim was to examine the secular trends and regional variations in pharmacotherapy of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) in Germany. We used nationwide drug prescription data of outpatient care (2...

Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients.
https://doi.org/10.1177/01939459211031988
Western Journal of Nursing Research; Liu S, Nwabueze C et. al.

Jul 25th, 2021 - This study examined the associations of polysubstance use, mood disorders, and chronic conditions with the history of anxiety disorder among patients with opioid use disorder (OUD). We performed a secondary analysis of the baseline data from a cli...

The Chronic Oral Administration of Clobenzorex or Amphetamine Decreases Motor Behavior ...
https://doi.org/10.1007/s12640-021-00395-1 10.1111/jnc.12114 10.1038/npp.2013.307 10.1016/j.ejphar.2004.02.001 10.1177/106002809703100706 10.1523/JNEUROSCI.3834-03.2004 10.1152/ajpregu.1995.268.1.R14 10.1007/BF03033567 10.1007/s12640-014-9505-9 10.1007/s12640-012-9334-7 10.1007/s002130100727 10.1520/JFS14056J 10.1016/0892-0362(94)90033-7 10.1038/bjp.2008.124 10.1016/0006-8993(92)90201-J 10.1111/jnc.12201 10.1016/j.forsciint.2013.02.001 10.1124/pr.114.010397 10.1002/(SICI)1098-2396(199902)31:2<154::AID-SYN9>3.0.CO;2-K 10.1016/j.aap.2005.11.005 10.1016/j.lfs.2013.07.014 10.1177/0269881113482532 10.1016/0091-3057(81)90056-3 10.1037/0033-2909.134.2.301 10.1016/S0169-328X(98)00040-0 10.1176/jnp.15.2.215 10.1007/s00213-011-2383-4 10.1111/j.1369-1600.2007.00083.x 10.1111/j.1369-1600.2007.00083.x 10.3389/fphar.2012.00121 10.1016/j.brainresrev.2009.03.002 10.1196/annals.1369.003 10.1002/syn.21654 10.1111/ejn.12361 10.1016/j.ntt.2012.01.007 10.1016/j.jchemneu.2017.03.001 10.1016/S0014-2999(98)00758-4 10.1196/annals.1432.041 10.1016/j.pharmthera.2014.05.001 10.1016/j.neuro.2015.08.006 10.1016/j.pneurobio.2015.09.011 10.1016/j.vibspec.2016.09.015 10.1016/0006-8993(92)90713-J 10.1016/0197-0186(94)00106-5 10.1016/S0893-133X(00)00097-X 10.1007/s12640-018-9990-3 10.1007/BF02854904 10.1016/0006-8993(82)90198-6 10.1016/0006-8993(84)91221-6 10.1007/s00213-005-2188-4 10.1186/1742-2094-9-52 10.1111/bph.12667 10.1016/j.neuroimage.2010.01.055 10.1007/s00401-009-0619-8 10.1124/jpet.102.044982 10.1016/j.pneurobio.2005.04.003 10.1177/019262330002800109 10.1016/j.bbr.2016.12.010 10.1016/j.brainres.2005.05.049 10.1016/j.neulet.2004.06.065 10.1097/00008877-200305000-00003 10.1016/S0002-9270(02)05106-7 10.1093/jat/24.7.606 10.1176/appi.ajp.158.3.377 10.1002/1098-2396(20010101)39:1<1::AID-SYN1>3.0.CO;2-7 10.1016/0024-3205(93)90243-V 10.1111/j.1749-6632.2009.05141.x 10.1016/S0091-3057(96)00329-2
Neurotoxicity Research; Apóstol Del Rosal GD, Limón ID et. al.

Jul 20th, 2021 - Described as amphetamine-like due to their structural and stimulant similarities, clobenzorex is one of the five most-commonly used drugs in Mexico for the treatment of obesity. Various studies have shown that amphetamines induce dopaminergic neur...

see more →

Guidelines  1 results

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendation...
https://www.ncbi.nlm.nih.gov/pubmed/22303521
Annals of Clinical Psychiatry : Official Journal of the A... Beaulieu S, Saury S et. al.

Feb 4th, 2012 - Mood disorders, especially bipolar disorder (BD), frequently are associated with substance use disorders (SUDs). There are well-designed trials for the treatment of SUDs in the absence of a comorbid condition. However, one cannot generalize these ...

see more →

Drugs  43 results see all →

News  80 results

Malpractice Case: Dangers When Taking Over a Patient's Care
https://www.medscape.com/viewarticle/921888

Dec 9th, 2019 - In handling a hospital transfer patient, a receiving specialist may have a new patient who has ongoing issues and is taking multiple medications. Discontinuing medications initiated before the transfer without probing the basis for the therapy car...

Malpractice Case: Dangers When Taking Over a Patient's Care
https://www.staging.medscape.com/viewarticle/921888

Dec 9th, 2019 - In handling a hospital transfer patient, a receiving specialist may have a new patient who has ongoing issues and is taking multiple medications. Discontinuing medications initiated before the transfer without probing the basis for the therapy car...

Death Certificate Project Accuses 64 Calif. Doctors
https://www.medpagetoday.com/painmanagement/opioids/81954?comment=true

Sep 3rd, 2019 - The so-called Death Certificate Project initiated by the Medical Board of California that began in 2015 has now resulted in formal accusals of wrongdoing filed against 64 physicians related to their drug prescribing, primarily involving opioids, n...

Opioids in Pregnancy Threaten Baby
https://www.medpagetoday.com/obgyn/pregnancy/80764

Jun 28th, 2019 - Infants exposed to maternal opioid use were at a higher risk of adverse outcomes in the short- and long-term, according to data from the Boston Birth Cohort, a prospectively followed sample of mostly urban, low-income, and multiethnic women. In a ...

see more →

Patient Education  1 results see all →